MY143574A - Carbamate compounds as 5-ht4 receptor agonists - Google Patents

Carbamate compounds as 5-ht4 receptor agonists

Info

Publication number
MY143574A
MY143574A MYPI20064472A MYPI20064472A MY143574A MY 143574 A MY143574 A MY 143574A MY PI20064472 A MYPI20064472 A MY PI20064472A MY PI20064472 A MYPI20064472 A MY PI20064472A MY 143574 A MY143574 A MY 143574A
Authority
MY
Malaysia
Prior art keywords
compounds
receptor agonists
carbamate compounds
carbamate
receptor
Prior art date
Application number
MYPI20064472A
Other languages
English (en)
Inventor
Daniel D Long
Choi Seok-Ki
Paul R Fatheree
Adam A Goldblum
Marquess Daniel
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of MY143574A publication Critical patent/MY143574A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
MYPI20064472A 2005-11-22 2006-11-09 Carbamate compounds as 5-ht4 receptor agonists MY143574A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73870205P 2005-11-22 2005-11-22

Publications (1)

Publication Number Publication Date
MY143574A true MY143574A (en) 2011-05-31

Family

ID=38067868

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20064472A MY143574A (en) 2005-11-22 2006-11-09 Carbamate compounds as 5-ht4 receptor agonists

Country Status (20)

Country Link
US (2) US7329752B2 (enExample)
EP (1) EP1960396B1 (enExample)
JP (1) JP2009516745A (enExample)
KR (1) KR20080072727A (enExample)
CN (1) CN101312967B (enExample)
AR (1) AR057627A1 (enExample)
AT (1) ATE448224T1 (enExample)
AU (1) AU2006318507A1 (enExample)
BR (1) BRPI0618835A2 (enExample)
CA (1) CA2630222A1 (enExample)
DE (1) DE602006010432D1 (enExample)
EA (1) EA014819B1 (enExample)
ES (1) ES2336952T3 (enExample)
MY (1) MY143574A (enExample)
NO (1) NO20082597L (enExample)
NZ (1) NZ567653A (enExample)
PE (1) PE20070954A1 (enExample)
TW (1) TW200804366A (enExample)
WO (1) WO2007062058A2 (enExample)
ZA (1) ZA200804010B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006094063A1 (en) * 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
ATE509021T1 (de) * 2006-02-16 2011-05-15 Theravance Inc Verfahren zur herstellung von zwischenverbindungen zu 5-ht4-rezeptoragonist- verbindungen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231413B (it) 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
US5223511A (en) * 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
JP3829879B2 (ja) * 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
IT1275903B1 (it) * 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
IT1298271B1 (it) 1998-02-18 1999-12-20 Boehringer Ingelheim Italia Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico
EP1173168A2 (en) * 1999-04-28 2002-01-23 Respiratorius AB Compound for use as a medicament for treatment of disorders involving bronchocontraction
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
JP4181847B2 (ja) * 2002-10-25 2008-11-19 エルピーダメモリ株式会社 タイミング調整回路、半導体装置及びタイミング調整方法
DK1664036T3 (da) * 2003-09-03 2012-02-13 Pfizer Benzimidazolonforbindelser med 5-HT4-receptoragonistisk virkning
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
ATE441646T1 (de) * 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
ATE431824T1 (de) * 2004-11-05 2009-06-15 Theravance Inc Chinolinon-carboxamid-verbindungen
WO2006069125A1 (en) * 2004-12-22 2006-06-29 Theravance, Inc. Indazole-carboxamide compounds
WO2006094063A1 (en) * 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
US7351304B2 (en) * 2005-05-24 2008-04-01 General Electric Company Method and apparatus for reducing surface defects
ATE495171T1 (de) 2005-06-07 2011-01-15 Theravance Inc Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors

Also Published As

Publication number Publication date
US20080090811A1 (en) 2008-04-17
CA2630222A1 (en) 2007-05-31
EA200801402A1 (ru) 2008-10-30
CN101312967A (zh) 2008-11-26
WO2007062058A3 (en) 2007-09-07
AU2006318507A1 (en) 2007-05-31
EP1960396B1 (en) 2009-11-11
NO20082597L (no) 2008-06-10
US7851467B2 (en) 2010-12-14
US7329752B2 (en) 2008-02-12
WO2007062058A2 (en) 2007-05-31
DE602006010432D1 (de) 2009-12-24
BRPI0618835A2 (pt) 2011-09-13
ATE448224T1 (de) 2009-11-15
ZA200804010B (en) 2009-02-25
AR057627A1 (es) 2007-12-05
PE20070954A1 (es) 2007-09-10
NZ567653A (en) 2011-06-30
TW200804366A (en) 2008-01-16
ES2336952T3 (es) 2010-04-19
JP2009516745A (ja) 2009-04-23
CN101312967B (zh) 2011-08-24
KR20080072727A (ko) 2008-08-06
EP1960396A2 (en) 2008-08-27
US20070117796A1 (en) 2007-05-24
EA014819B1 (ru) 2011-02-28

Similar Documents

Publication Publication Date Title
ZA200705115B (en) Indazole-carboxamide compounds
TW200531692A (en) Aryl aniline derivatives as β2 adrenergic receptor agonists
MY155036A (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
WO2005121065A3 (en) DIAMINE β2 ADRENERGIC RECEPTOR AGONISTS
DE602008005771D1 (de) Disubstituierte alkyl-8-azabicycloä3.2.1üoktan-verbindungen als mu-opioid-rezeptorantagonisten
TW200800981A (en) 8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
ATE441646T1 (de) 5-ht4-rezeptoragonistenverbindungen
MY143581A (en) Carboxamide derivatives as muscarinic receptor antagonists
MY154962A (en) Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a seratonin receptor
WO2006052889A3 (en) Quinolinone-carboxamide compounds
BRPI0507791A (pt) compostos de indazol-carboxamida como agonistas do receptor 5-ht4
MX2010002171A (es) Compuestos 8-azabiciclo[3.2.1] octil-2 hidroxibenzamida como antagonistas de los receptores opioides mu.
ATE495171T1 (de) Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors
TW200638930A (en) Acetylene derivatives
TW200740814A (en) Compounds
TW200716568A (en) 1H-quinazoline-2,4-diones
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
MY149973A (en) 3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists
TW200714587A (en) Biphenyl compounds useful as muscarinic receptor antagonists
MY147756A (en) Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
MX2007010769A (es) Compuestos de quinolina como agonistas de receptor 5-ht4.
CO6390054A2 (es) Formas cristalinas de un compuesto 3-carboxipropil-aminotetralina
TW200722418A (en) Novel compounds
MY143574A (en) Carbamate compounds as 5-ht4 receptor agonists
UA83142C2 (en) 3-aminocyclopentane carboxyamidine as modulators of chemokine receptors